American Century Companies
EDIT icon

American Century Companies’s Editas Medicine EDIT Stock Holding History

American Century Companies’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-147,971
Closed -$505K – 2905
2024
Q3 		$505K Buy
147,971
+21,731
+17% +$94.6K ﹤0.01% 2471
2024
Q2 		$590K Buy
126,240
+15,088
+14% +$85.1K ﹤0.01% 2380
2024
Q1 		$825K Buy
111,152
+29,094
+35% +$242K ﹤0.01% 2230
2023
Q4 		$831K Buy
82,058
+28,250
+53% +$248K ﹤0.01% 2150
2023
Q3 		$420K Buy
53,808
+19,451
+57% +$167K ﹤0.01% 2336
2023
Q2 		$283K Buy
34,357
+16,827
+96% +$147K ﹤0.01% 2411
2023
Q1 		$123K Buy
17,530
+3,507
+25% +$31.2K ﹤0.01% 2515
2022
Q4 		$124K Buy
+14,023
New +$154K ﹤0.01% 2425
2022
Q2 		– Sell
-198,110
Closed -$3.77M – 2325
2022
Q1 		$3.77M Hold
198,110
– – ﹤0.01% 1200
2021
Q4 		$5.26M Hold
198,110
– – ﹤0.01% 1043
2021
Q3 		$8.14M Buy
198,110
+343
+0.2% +$18.8K 0.01% 903
2021
Q2 		$11.2M Hold
197,767
– – 0.01% 788
2021
Q1 		$8.31M Sell
197,767
-24,243
-11% -$1.38M 0.01% 817
2020
Q4 		$15.6M Sell
222,010
-68,547
-24% -$2.82M 0.01% 675
2020
Q3 		$8.15M Hold
290,557
– – 0.01% 747
2020
Q2 		$8.6M Sell
290,557
-51,332
-15% -$1.34M 0.01% 711
2020
Q1 		$6.78M Sell
341,889
-33,994
-9% -$857K 0.01% 676
2019
Q4 		$11.1M Buy
375,883
+488
+0.1% +$12.2K 0.01% 654
2019
Q3 		$8.54M Sell
375,395
-60,438
-14% -$1.5M 0.01% 645
2019
Q2 		$10.8M Buy
435,833
+49,567
+13% +$1.18M 0.01% 617
2019
Q1 		$9.44M Buy
386,266
+39,592
+11% +$896K 0.01% 631
2018
Q4 		$7.89M Buy
+346,674
New +$9.43M 0.01% 662
2018
Q2 		– Sell
-192,873
Closed -$6.39M – 1302
2018
Q1 		$6.39M Sell
192,873
-110,087
-36% -$3.92M 0.01% 771
2017
Q4 		$9.31M Sell
302,960
-9,269
-3% -$233K 0.01% 658
2017
Q3 		$7.5M Buy
+312,229
New +$5.94M 0.01% 735

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies's EDIT Position: Q4 2024 in Review

American Century Companies sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 147,971 shares — an estimated $505K sold.

American Century Companies first reported a position in EDIT in Q3 2017 and held it in 25 quarters. The position peaked at $15.6M in Q4 2020. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • American Century Companies reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • American Century Companies sold 147,971 Editas Medicine shares in Q4 2024, an estimated $505K.
  • American Century Companies first reported a position in Editas Medicine in Q3 2017 and held it in 25 quarters.
  • American Century Companies's Editas Medicine position peaked at $15.6M in Q4 2020.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on American Century Companies's 13F filing for Q4 2024, filed 11 Feb 2025.